Back to top

Ambry Genetics and Invicro Announce Partnership to Provide Enhanced Capabilities with Advanced Genomics Services to Enable Precision Medicine

February 6, 2018
No votes yet
Technology

Summary/Abstract

Ambry Genetics Corporation (Ambry), leaders in genetic testing, announced today they will partner with Invicro, a leading provider of imaging services and software for research and drug development, to provide customized genomics and imaging services for the pharmaceutical and biotechnology industry, with a specialized focus on oncology and neurodegenerative diseases.

Both Invicro and Ambry Genetics were acquired by Konica Minolta in 2017 as a part of Konica Minolta's expansion into the clinical healthcare space.